Immunostaining of Ki-67 (cell proliferation marker) and E-Cadherin in a primary pancreatic cancer
Metastatic Pancreatic Cancer
Immunostaining of Ki-67 (cell proliferation marker) and E-Cadherin in a primary pancreatic cancer
Who We Are
​We are a biomedical research team at the Barbara Ann Karmanos Cancer Institute and Wayne State University in Detroit, Michigan.
Between 2001-2021, our group was continuously supported by a grant from the National Cancer Institute.
What We Do
We study the biology of normal mammary gland development and breast cancer. In addition, we examine the genetic alterations that drive pancreatic carcinogenesis.
​We develop novel genetically engineered models to study biological processes in vivo.
Contact Us
For more information about what we do, to join our team, or to financially support our research
​Leave a message here
November 19, 2025:
A new report from our team on the STAT protein-independent functions of Janus kinases in early mammary gland development has been accepted for publication in Cell Reports.
Areas of Expertise
Mammary Gland Development
​Breast Cancer
Pancreatic Cancer
​Cytokine Signaling
Genome Engineering
​In Vivo Cancer Progression Models
​Tumor Cell Dormancy​